Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US6214828A · kind A · utility
8Cited by
13References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 1998 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Nov 12, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds, such as: ##STR1## ##STR2## are disclosed. Also disclosed are methods for inhibiting the abnormal growth of cells, for inhibiting farnesyl protein transferase and for treating cancers using the novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.